ROCK SPRINGS CAPITAL

ROCK SPRINGS CAPITAL MANAGEMENT LP Legal Name

Adviser information for ROCK SPRINGS CAPITAL last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.

Advisory Business

Type of Organization Limited Partnership
Fiscal Year End DECEMBER
Legal Location Delaware, United States

Employees

Total Number of Employees 18
Investment Advisory/Research 7
Registered Broker-Dealer Representatives 0
Registered State Investment Advisers 0
Licensed Agents of an Insurance Company 0
No. of Firms/People that Solicit Clients 0

RAUM

Provides Management of Securities Portfolios Yes
Type Accounts RAUM
Discretionary 6 $5.8B
Non-Discretionary 0 $0
Total 6 $5.8B

Clients

Type Number RAUM
Individuals 0 $0
HNW Individuals 0 $0
Banking or thrift institutions 0 $0
Investment companies 0 $0
Business development companies 0 $0
Pooled investment vehicles 6 $5.8B
Pension and profit sharing plans 0 $0
Charitable organizations 0 $0
State or municipal gov entities 0 $0
Other investment advisers 0 $0
Insurance companies 0 $0
Sovereign wealth funds and foreign official institutions 0 $0
Corporations or other businesses 0 $0
Other 0 $0
Type Number
No. of Non-RAUM Clients 0
No. of Non-U.S. Clients 67

Services

Advisory Services Portfolio management for pooled investment vehicles
Compensation % of AUMPerformance-based fees
Other Business Activities Commodity pool operator or commodity trading advisor

Identifiers

SEC RIA File Number 801-78511
SEC ERA File Number 801-78511
SEC CIK Numbers 1595725
SEC CRD Numbers 168648
Legal Entity Identifier 5493004NKG0T3VM7NZ08

Principal Office

650 S. EXETER STREET
SUITE 1070
BALTIMORE
MD
United States
Monday - Friday, 8:00 AM - 6:00 PM
Tel: 410-220-0130, Fax: 410-220-0144

Chief Compliance Officer

AIDAN O'CONNOR
GENERAL COUNSEL
650 S. EXETER STREET
SUITE 1070
BALTIMORE
MD
United States
Tel: 410-220-0130
Fax: 410-220-0144
(Full email address available in API data)

Regulatory Contact

MARK BUSSARD
MEMBER
650 S. EXETER STREET
SUITE 1070
BALTIMORE
MD
United States
Tel: 410-220-0130
Fax: 410-220-0144
(Full email address available in API data)

Industry Affiliates

FOUR PINES GENERAL PARTNER LLC Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles
ROCK SPRINGS GENERAL PARTNER LLC Other investment adviser, including financial plannersCommodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles

Private Funds

Name Type Assets $USD Min Investment $USD No. Owners
FOUR PINES MASTER FUND LP Hedge Fund $263.7M $10.0M 25
ROCK SPRINGS CAPITAL MASTER FUND LP Hedge Fund $5,505.0M $10.0M 635

Control Persons

Name Type Entity Title Since Ownership
ROCK SPRINGS CAPITAL LLC Domestic Entity GENERAL PARTNER 03/2013 < 5%
BUSSARD, GORDON, MARGRAF ("MARK") Individual MEMBER/LIMITED PARTNER 03/2013 25-50%
MCPHAIL, GRAHAM, MORGAN Individual MEMBER/LIMITED PARTNER 03/2013 25-50%
JENNER, KRIS, HARLAN Individual MEMBER/LIMITED PARTNER 03/2013 25-50%
BUSSARD, GORDON, MARGRAF ("MARK") Individual ROCK SPRINGS CAPITAL LLC MEMBER 03/2013 25-50%
MCPHAIL, GRAHAM, MORGAN Individual ROCK SPRINGS CAPITAL LLC MEMBER 03/2013 25-50%
JENNER, KRIS, HARLAN Individual ROCK SPRINGS CAPITAL LLC MEMBER 03/2013 25-50%
ETOH, NNAMDI, C Individual CHIEF FINANCIAL OFFICER 01/2021 < 5%
O'CONNOR, AIDAN, HUGH Individual CHIEF COMPLIANCE OFFICER AND GENERAL COUNSEL 10/2022 < 5%

No. Employees, Historic

30150201920202021202220232024202519 on 4/17/201919 on 2/3/202017 on 3/30/202019 on 3/31/202121 on 3/31/202221 on 11/8/202220 on 3/31/202318 on 3/27/2024

RAUM, Historic

6B3B020192020202120222023202420252418712705 on 4/17/20192418712705 on 2/3/20203569900876 on 3/30/20205523324381 on 3/31/20215884695405 on 3/31/20225884695405 on 11/8/20225716429633 on 3/31/20235768717819 on 3/27/2024

No. Clients, Historic

105020192020202120222023202420252 on 4/17/20192 on 2/3/20206 on 3/30/20206 on 3/31/20216 on 3/31/20226 on 11/8/20226 on 3/31/20236 on 3/27/2024

Holdings

From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name Class Value $USD # Shares Private Fund
ACADIA HEALTHCARE COMPANY IN COM 80M 1M
ACCOLADE INC COM 8M 2M
ACLARIS THERAPEUTICS INC COM 3M 3M
ACUMEN PHARMACEUTICALS INC COM 6M 2M
ADAPTIMMUNE THERAPEUTICS PLC SPONDS ADR 2M 2M
AGILON HEALTH INC COM 58M 9M
AGIOS PHARMACEUTICALS INC COM 45M 1M
AKERO THERAPEUTICS INC COM 25M 1M
ALIGN TECHNOLOGY INC COM 31M 128K
ALLAKOS INC COM 1M 1M
ALNYLAM PHARMACEUTICALS INC COM 61M 250K
AMICUS THERAPEUTICS INC COM 12M 1M
APELLIS PHARMACEUTICALS INC COM 5M 141K
APPLIED THERAPEUTICS INC COM 7M 2M
ARGENX SE SPONSORED ADR 99M 229K
ASCENDIS PHARMA A/S SPONSORED ADR 40M 290K
AURINIA PHARMACEUTICALS INC COM 7M 1M
AUTOLUS THERAPEUTICS PLC SPON ADS 4M 1M
AZENTA INC COM 37M 696K
BEAM THERAPEUTICS INC COM 6M 250K
BIOCRYST PHARMACEUTICALS INC COM 22M 4M
BIOHAVEN LTD COM 4M 128K
BIOMARIN PHARMACEUTICAL INC COM 12M 151K
BIOMEA FUSION INC COM 815K 181K
BLUEPRINT MEDICINES CORP COM 265M 2M
BLUEPRINT MEDICINES CORP COM 6M 57K
BOSTON SCIENTIFIC CORP COM 63M 818K
CELLDEX THERAPEUTICS INC NEW COM NEW 52M 1M
CHARLES RIV LABS INTL INC COM 12M 60K
COMPASS THERAPEUTICS INC COM 6M 6M
COMPUGEN LTD ORD 2M 990K
CRINETICS PHARMACEUTICALS IN COM 13M 289K
CULLINAN THERAPEUTICS INC COM 11M 658K
DEXCOM INC COM 57M 500K
DYNAVAX TECHNOLOGIES CORP COM NEW 15M 1M
DYNE THERAPEUTICS INC COM 16M 461K
EDAP TMS S A SPONSORED ADR 8M 1M
EDWARDS LIFESCIENCES CORP COM 51M 550K
ELI LILLY & CO COM 110M 122K
ENLIVEN THERAPEUTICS INC COM 10M 429K
ESSA PHARMA INC COM NEW 4M 677K
EVOLENT HEALTH INC CL A 78M 4M
EXACT SCIENCES CORP COM 46M 1M
FRESHPET INC COM 62M 480K
FULCRUM THERAPEUTICS INC COM 5M 728K
GOSSAMER BIO INC NOTE 5.000% 6/0 5M
GOSSAMER BIO INC COM 3M 3M
HUMANA INC COM 55M 147K
IDEXX LABS INC COM 58M 120K
IMMUNOCORE HLDGS PLC ADS 14M 419K
IMMUNOVANT INC COM 31M 1M
INOZYME PHARMA INC COM 16M 4M
INSMED INC COM PAR $.01 54M 808K
INSPIRE MED SYS INC COM 17M 130K
INSULET CORP COM 39M 195K
INTUITIVE SURGICAL INC COM NEW 133M 299K
IRHYTHM TECHNOLOGIES INC COM 43M 398K
JASPER THERAPEUTICS INC COM NEW 9M 404K
JOHNSON & JOHNSON COM 25M 170K
KORRO BIO INC COM 1M 36K
KRYSTAL BIOTECH INC COM 19M 106K
KYMERA THERAPEUTICS INC COM 35M 1M
KYVERNA THERAPEUTICS INC COM 1M 179K
LEAP THERAPEUTICS INC COM NEW 2M 1M
LEGEND BIOTECH CORP SPONSORED ADS 22M 506K
LIFESTANCE HEALTH GROUP INC COM 24M 5M
MACROGENICS INC COM 4M 1M
MADRIGAL PHARMACEUTICALS INC COM 69M 245K
MEREO BIOPHARMA GROUP PLC SPON ADS 33M 9M
MERSANA THERAPEUTICS INC COM 6M 3M
MERUS N V COM 59M 1M
MINERALYS THERAPEUTICS INC COM 4M 379K
MIRUM PHARMACEUTICALS INC COM 61M 2M
NEUMORA THERAPEUTICS INC. COM 7M 760K
NEUROCRINE BIOSCIENCES INC COM 129M 940K
NEVRO CORP NOTE 2.750% 4/0 483K
NEVRO CORP COM 12M 1M
NOVAVAX INC COM NEW 9M 675K
NOVO-NORDISK A S ADR 21M 148K
NUVALENT INC COM 19M 256K
NUVATION BIO INC *W EXP 07/07/202 21K 134K
OLINK HLDG AB SPONSORED ADS 13M 500K
OSCAR HEALTH INC CL A 20M 1M
PACIRA BIOSCIENCES INC COM 22M 785K
PENUMBRA INC COM 48M 265K
PERSPECTIVE THERAPEUTICS INC COM NEW 4M 401K
PHARVARIS N V COM 14M 757K
PHREESIA INC COM 51M 2M
PLIANT THERAPEUTICS INC COM 4M 385K
PROTHENA CORP PLC SHS 13M 625K
PULMONX CORP COM 4M 652K
REVOLUTION MEDICINES INC COM 37M 943K
RHYTHM PHARMACEUTICALS INC COM 53M 1M
SAGIMET BIOSCIENCES INC COM SER A 3M 788K
SAREPTA THERAPEUTICS INC COM 45M 284K
SPRINGWORKS THERAPEUTICS INC COM 8M 200K
SPRUCE BIOSCIENCES INC COM 1M 3M
STRUCTURE THERAPEUTICS INC SPONSORED ADS 3M 66K
STRUCTURE THERAPEUTICS INC SPONSORED ADS 39M 1000K
TALPHERA INC COM NEW 282K 316K
TRAVERE THERAPEUTICS INC COM 37M 4M
TRAVERE THERAPEUTICS INC NOTE 2.500% 9/1 3M
ULTRAGENYX PHARMACEUTICAL IN COM 79M 2M
UNITEDHEALTH GROUP INC COM 140M 275K
VERA THERAPEUTICS INC CL A 14M 381K
VIGIL NEUROSCIENCE INC COM 2M 472K
VINCERX PHARMA INC COM NEW 722K 892K
WARBY PARKER INC CL A COM 33M 2M
WEST PHARMACEUTICAL SVSC INC COM 48M 146K
XENON PHARMACEUTICALS INC COM 50M 1M
XILIO THERAPEUTICS INC COM 3M 3M
ZAI LAB LTD ADR 22M 1M